53669-44-6

Upstream product

• 937244-43-4 benzyl-2-[2-(benzyloxy)phenyl]-2-oxazole-3-methyl-4-carboxylate 
• 1189053-72-2 (4S,5S)-2-(2-hydroxyphenyl)-5-methyl-4,5-dihydrooxazole-4-carboxylic acid 
• 14389-86-7 2-benzyloxybenzoic acid 
• 370103-09-6 (2S,3R)-benzyl 2-(2-(benzyloxy)phenylamido)-3-hydroxybutanoate 

Downstream Products

• 937244-48-9 (R)-methyl 6-(N-(benzyloxy)formamido)-2-(2-(2-hydroxyphenyl)-5-methyloxazole-4-carboxamido)hexanoate 
• 1326220-46-5 C₂₅H₂₇N₃O₇ 
• 1309782-00-0 C₄₈H₆₁N₅O₁₀ 
• 1309782-11-3 C₄₈H₆₁N₅O₁₀ 
• 1007123-27-4 2,5-dioxopyrrolidin-1-yl 2-(2-hydroxyphenyl)-5-methyloxazole-4-carboxylate 

Relevant academic research and scientific papers

Structure-activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters

During the syntheses and studies of natural iron chelators (mycobactins), we serendipitously discovered that a simple, small molecule, oxazoline-containing intermediate 3 displayed surprising anti-tuberculosis activity (MIC of 7.7?μM, average). Herein we

Syntheses of amamistatin fragments and determination of their HDAC and antitumor activity

Amamistatins A and B are natural products found to have anti-proliferative effects against MCF-7, A549, and MKN45 human tumor cell lines (IC50 0.24-0.56 μM). It was proposed that their activity was due to histone deacetylase (HDAC) inhibition m